Bispecific Antibodies: Redefining Relapse/Refractory Treatment in Follicular Lymphoma

Name: Bispecific Antibodies: Redefining Relapse/Refractory Treatment in Follicular Lymphoma
Start: 2024-09-28T16:00:00+02:00
End: 2024-09-28T17:30:00+02:00

Event Details:

September 28, 2024 @ 4:00 pm - 5:30 pm

Title:

Bispecific Antibodies: Redefining Relapse/Refractory Treatment in Follicular Lymphoma

Speakers:

Chaired by:

Brought to us by:

Agenda:

See more events

Clinical Haematology Fellowship Funding Opportunity

BACK TO PROJECTS

All resources showcased on this website are provided by SACHaS in collaboration with our partners.

admin@sachas.org.za.www51.cpt2.host-h.net

SACHaS NPC is registered in South Africa with Company Reg. No: 2012/206028/08, Public Benefit Organisation ref. No: 930074964, and PBO registration number: 930074964.

Organizations that have been validated by CAF International have completed an extensive application and due diligence process with one of CAF International’s Global Offices. The CAF International Validated Organization Badge is awarded to organizations that are structured and operated as nonprofit entities. This is confirmed by a validation process that goes far beyond a simple reliance on a foreign government database.

In strategic partnership with:

ABOUT
CONTACT
COOKIE POLICY
PRIVACY POLICY
POPIA STATEMENT
ANNUAL FINANCIAL STATEMENTS